Latest current cash for SYRA: $2.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for SYRA is $2.1M as of June 2026. That compares with $2.3M in the prior-year period — down 7.9% year over year. Investors often review this figure alongside Syra Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, SYRA's current cash moved from $2.3M to $2.1M — a 7.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Syra Health's operating scale or balance-sheet position.
A current cash figure of $2.1M for SYRA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting SYRA's current cash ($2.1M), review year-over-year change from $2.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.